Xiaoning (Shelly) Wang, Ph.D.

Group Leader PKPD, Principal Scientist II

Shelly joined Metrum in 2018. She brings 11 years of pharmaceutical industry experience in the area of pharmacometrics. She earned her Ph.D. degree in Biomedical Engineering from the University of Southern California.

Shelly’s clinical experience includes clinical pharmacology in pediatrics, oncology, and immuno-science. She plans to continue her research in the application of pharmacokinetic and pharmacodynamic modeling and simulations in drug development.

Recent publications by this scientist

Population Pharmacokinetic Analysis for Comparison of Pexidartinib Exposure in Asian and Non-Asian Patients

November 21, 2019

Chia-Chi Lin, Jun Guo, William D. Tap, Andrew J. Wagner, Silvia Stacchiotti, Jih-Hsiang Lee, Xiaoning Wang, Jia Kang, Hamim Zahir, Shun-ichi Sasaki, Ophelia Yin

Poster presented at the 2019 Connective Tissue Oncology Society annual meeting in Toyko, Japan. 14 Nov 2019

Download PDF